
First-in-Class Endometriosis Rx Given Green Light by MHRA
The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved a new treatment, relugolix combination therapy, for endometriosis in adult women. This therapy includes a GnRH receptor antagonist to reduce hormone levels and ease symptoms. Endometriosis affects 1 in 10 women and can cause intense pain and impact daily life. Clinical trials showed positive results,…